Vernakalant Injection 20 mg/mL

DRUG2 trials

Sponsors

Advanz Pharma

Conditions

Atrial FibrillationAtrial Flutter

Phase 2

A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter

CompletedNCT00476112

Advanz PharmaAtrial Flutter

Start: 2003-08-31End: 2004-09-30Updated: 2008-04-02

Phase 3

Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation

CompletedNCT00468767

Advanz PharmaAtrial Fibrillation

Start: 2003-08-31End: 2004-11-30Updated: 2008-04-02